Guilford Street Labs

Guilford Street Laboratories develops blood tests that diagnose rare, cardiac and neurodegenerative diseases such as Parkinson’s, Alzheimer’s and hypertrophic cardiomyopathy. GSL is a spinout of University College London (UCL). It combines mass spectrometry and machine learning to find disease markers in a patient’s blood, so diagnosis can come earlier, faster and at lower cost. Two of its tests have received FDA Breakthrough Device Designation. Through CoreLabs, GSL also runs specialist biomarker testing for pharma, biotech and academic partners worldwide.